Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review.
MIS-C
disability
heparin
prophylaxis
thrombosis
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
25 Mar 2023
25 Mar 2023
Historique:
received:
30
01
2023
revised:
14
03
2023
accepted:
20
03
2023
medline:
16
5
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Multisystem Inflammatory Syndrome in Children (MIS-C) is a systemic hyperinflammatory disorder that is associated with a hypercoagulable state and a higher risk of thrombotic events (TEs). We report the case of a 9-year-old MIS-C patient with a severe course who developed a massive pulmonary embolism that was successfully treated with heparin. A literature review of previous TEs in MIS-C patients was conducted (60 MIS-C cases from 37 studies). At least one risk factor for thrombosis was observed in 91.7% of patients. The most frequently observed risk factors were pediatric intensive care unit hospitalization (61.7%), central venous catheter (36.7%), age >12 years (36.7%), left ventricular ejection fraction <35% (28.3%), D-dimer >5 times the upper limit of normal values (71.9%), mechanical ventilation (23.3%), obesity (23.3%), and extracorporeal membrane oxygenation (15%). TEs may concurrently affect multiple vessels, including both arterial and venous. Arterial thrombosis was more frequent, mainly affecting the cerebral and pulmonary vascular systems. Despite antithrombotic prophylaxis, 40% of MIS-C patients developed TEs. Over one-third of patients presented persistent focal neurological signs, and ten patients died, half of whom died because of TEs. TEs are severe and life-threatening complications of MIS-C. In case with thrombosis risk factors, appropriate thromboprophylaxis should be promptly administered. Despite proper prophylactic therapy, TEs may occur, leading in some cases to permanent disability or death.
Identifiants
pubmed: 37189867
pii: children10040618
doi: 10.3390/children10040618
pmc: PMC10137057
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
ASAIO J. 2021 Jan 1;67(1):7-11
pubmed: 33346988
Front Pediatr. 2022 Jan 24;9:814033
pubmed: 35141182
Pediatr Radiol. 2020 Sep;50(10):1479-1480
pubmed: 32705305
Blood. 2021 Jul 15;138(2):190-198
pubmed: 33895804
Front Pediatr. 2021 Jun 25;9:656720
pubmed: 34249807
N Engl J Med. 2020 Jul 23;383(4):347-358
pubmed: 32598830
Front Pediatr. 2021 May 14;9:669453
pubmed: 34055700
Brain Disord. 2022 Sep;7:100051
pubmed: 36039103
Pediatrics. 2021 Aug;148(2):
pubmed: 34035074
Nat Rev Rheumatol. 2021 Dec;17(12):731-748
pubmed: 34716418
CASE (Phila). 2021 Aug;5(4):217-220
pubmed: 33817452
Childs Nerv Syst. 2020 Aug;36(8):1579-1580
pubmed: 32583150
Mediterr J Hematol Infect Dis. 2022 Mar 01;14(1):e2022028
pubmed: 35444772
Front Pediatr. 2022 Aug 11;10:944743
pubmed: 36034557
Lancet Child Adolesc Health. 2020 Sep;4(9):669-677
pubmed: 32653054
Crit Care. 2021 Apr 7;25(1):131
pubmed: 33827651
Pediatr Neurol. 2022 Jan;126:104-107
pubmed: 34768033
J Med Case Rep. 2013 Sep 10;7:223
pubmed: 24228906
Clin Pediatr (Phila). 2021 Jul;60(8):341-345
pubmed: 33980050
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Cardiol Young. 2022 Jan;32(1):138-141
pubmed: 34082849
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Indian J Crit Care Med. 2020 Nov;24(11):1089-1094
pubmed: 33384516
Pediatr Pulmonol. 2021 Jan;56(1):271-273
pubmed: 33095516
JACC Case Rep. 2022 Aug 03;4(15):945-949
pubmed: 35935155
Lancet Child Adolesc Health. 2021 Jan;5(1):88-90
pubmed: 33340468
J Pediatr. 2020 Sep;224:24-29
pubmed: 32553861
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Arthritis Rheumatol. 2022 Apr;74(4):e1-e20
pubmed: 35118829
Stroke. 2022 Aug;53(8):2497-2503
pubmed: 35380052
J Thromb Haemost. 2021 Jul;19(7):1764-1770
pubmed: 33872443
Pediatr Neurol. 2023 May;142:89-94
pubmed: 36418211
Pediatr Blood Cancer. 2022 May;69(5):e29426
pubmed: 34941014
AJNR Am J Neuroradiol. 2020 Dec;41(12):2348-2350
pubmed: 32816770
Heart Views. 2022 Apr-Jun;23(2):108-112
pubmed: 36213433
Perfusion. 2021 Jul;36(5):524-528
pubmed: 32900267
Paediatr Int Child Health. 2021 Aug;41(3):211-216
pubmed: 34488566
Indian J Pediatr. 2022 Jul;89(7):726
pubmed: 35244880
Children (Basel). 2022 Oct 29;9(11):
pubmed: 36360381
Interv Neuroradiol. 2023 Apr;29(2):214-216
pubmed: 35167391
Pediatr Blood Cancer. 2021 Jul;68(7):e29049
pubmed: 33955167
Ann Pediatr Cardiol. 2022 Jan-Feb;15(1):90-93
pubmed: 35847408
Case Rep Infect Dis. 2021 Jan 18;2021:8872412
pubmed: 33532103
Case Rep Med. 2022 Sep 28;2022:3785103
pubmed: 36212082
Ann Neurol. 2021 Apr;89(4):657-665
pubmed: 33332607
Diagnostics (Basel). 2022 Apr 01;12(4):
pubmed: 35453932
J Thromb Haemost. 2020 Nov;18(11):3099-3105
pubmed: 33174388
Lancet Child Adolesc Health. 2020 Oct;4(10):790-794
pubmed: 32828177
Circulation. 2020 Aug 4;142(5):429-436
pubmed: 32418446
J Trop Pediatr. 2021 May 17;67(2):
pubmed: 34028528
J Pediatr. 2021 Mar;230:23-31.e10
pubmed: 33197493
Pediatr Blood Cancer. 2022 Sep;69(9):e29793
pubmed: 35689507
Pediatr Infect Dis J. 2022 May 1;41(5):e251-e252
pubmed: 35153289